A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors
Clinical trial NCT05810103 · UNKNOWN
Trial details
- NCT number
- NCT05810103
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2023-12-23
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.